• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1984年至1989年间菲尼斯泰尔省胃腺癌的治疗管理与生存情况]

[Therapeutic management and survival of gastric adenocarcinoma in the province of Finistère between 1984 and 1989].

作者信息

Le Page M, Cauvin J M, Le Dréau G, Nousbaum J B, Enard L, Gourlaouen A, Robaszkiewicz M, Gouérou H

机构信息

Service d'Hépato-Gastroentérologie, CH de Cornouaille, Quimper.

出版信息

Gastroenterol Clin Biol. 1995 Oct;19(10):804-10.

PMID:8566560
Abstract

OBJECTIVES

The aim of this study was to analyze the evolution of treatment regimens and survival rates of stomach adenocarcinoma recorded in the Finistère cancer registry from 1984 to 1989.

METHODS

In a population of 838,627 inhabitants, 1,280 patients with a gastric cancer were registered; 1,164 patients (693 males and 471 females) had an adenocarcinoma. Survival rates were estimated by the actuarial method, and compared using the logrank test and the Cox model.

RESULTS

Surgical resection was the main treatment for 661 patients (57%). The frequency of curative resection increased from 25% between 1984 and 1986 to 35% after 1986. Among the other patients, 39 (3%) were treated by chemotherapy and/or radiotherapy, and 53 patients (4%) by endoscopy alone; 253 patients had only symptomatic treatment. The survival rates of all patients were 43% at 1 year and 20% at 5 years. The median survival was 9.2 +/- 0.6 months. In patients with cancer managed surgically, the factors associated with a better prognosis were young age, long duration of symptoms before diagnosis, ulcerated macroscopic aspect, limited tumour extension and curative surgical resection. In other patients, 2 factors were associated a with better prognosis: the absence of metastases and an endoscopic palliative treatment.

CONCLUSIONS

Surgical resection is the main treatment of gastric adenocarcinoma. Although the frequency of surgery increased, the prognosis of gastric adenocarcinoma did not improve within this 6-year period.

摘要

目的

本研究旨在分析1984年至1989年在菲尼斯泰尔癌症登记处记录的胃腺癌治疗方案的演变和生存率。

方法

在838,627名居民中,登记了1,280例胃癌患者;1,164例患者(693例男性和471例女性)患有腺癌。通过精算方法估计生存率,并使用对数秩检验和Cox模型进行比较。

结果

661例患者(57%)的主要治疗方法是手术切除。根治性切除的频率从1984年至1986年期间的25%增加到1986年后的35%。在其他患者中,39例(3%)接受了化疗和/或放疗,53例患者(4%)仅接受了内镜治疗;253例患者仅接受了对症治疗。所有患者的1年生存率为43%,5年生存率为20%。中位生存期为9.2±0.6个月。在接受手术治疗的癌症患者中,与较好预后相关的因素是年轻、诊断前症状持续时间长、宏观上为溃疡型、肿瘤扩展有限和根治性手术切除。在其他患者中,有两个因素与较好预后相关:无转移和内镜姑息治疗。

结论

手术切除是胃腺癌的主要治疗方法。尽管手术频率增加,但在这6年期间胃腺癌的预后并未改善。

相似文献

1
[Therapeutic management and survival of gastric adenocarcinoma in the province of Finistère between 1984 and 1989].[1984年至1989年间菲尼斯泰尔省胃腺癌的治疗管理与生存情况]
Gastroenterol Clin Biol. 1995 Oct;19(10):804-10.
2
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.根治性胃切除术后辅助化疗的晚期胃癌患者15年随访期间预后因素模式的变化:韩国一家机构的15年随访研究
Ann Surg Oncol. 2007 Oct;14(10):2730-7. doi: 10.1245/s10434-007-9479-4. Epub 2007 Jul 14.
3
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?新辅助化疗后的组织学反应分级能否预测完全切除的胃癌患者的生存率?
Ann Surg Oncol. 2007 Dec;14(12):3412-8. doi: 10.1245/s10434-007-9574-6. Epub 2007 Oct 2.
4
[Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistère between 1984 and 1988 (716 cases)].[1984年至1988年菲尼斯泰尔省食管癌表皮样癌的治疗与生存情况(716例)]
Gastroenterol Clin Biol. 1993;17(1):9-16.
5
Results of immunochemo-surgery for gastric carcinoma.胃癌免疫化疗手术的结果。
Hepatogastroenterology. 2001 Sep-Oct;48(41):1227-30.
6
[Epidemiology and prognosis of gastric carcinomas at the province of Calvados. A 10-year study].[卡尔瓦多斯省胃癌的流行病学与预后。一项为期10年的研究]
Gastroenterol Clin Biol. 1995 Oct;19(10):797-803.
7
Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.进展期胃癌非根治性胃切除术后的化疗
Hepatogastroenterology. 1999 Mar-Apr;46(26):1238-43.
8
Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?手术切除的胃或食管腺癌患者采用放化疗治疗是否能改善预后?
Ann Surg Oncol. 2010 Jan;17(1):98-108. doi: 10.1245/s10434-009-0679-y. Epub 2009 Sep 24.
9
Clinical profile of carcinoma stomach at a tertiary care hospital in south India.印度南部一家三级护理医院胃癌的临床概况。
Trop Gastroenterol. 2004 Jan-Mar;25(1):21-6.
10
Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary?伴有远处转移的胃腺癌:是否有必要进行胃切除术?
Arch Surg. 2007 Feb;142(2):143-9; discussion 149. doi: 10.1001/archsurg.142.2.143.